REGULATION OF THYROID FUNCTION T4 AND T3 KINETICS
甲状腺功能 T4 和 T3 动力学的调节
基本信息
- 批准号:3226225
- 负责人:
- 金额:$ 29.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1978
- 资助国家:美国
- 起止时间:1978-12-01 至 1993-11-30
- 项目状态:已结题
- 来源:
- 关键词:amiodarone autoimmune disorder disease /disorder model embryo /fetus endocrine disorder chemotherapy female hormone metabolism hormone receptor hormone regulation /control mechanism human subject hyperthyroidism hypothyroidism immunosuppressive insulin dependent diabetes mellitus interferons iodination iodine laboratory rat lymphomatous thyroiditis neuropeptides newborn animals nutrition related tag placental transfer radioimmunoassay radionuclides radiotracer thalidomide thyroid function thyroid hormone binding protein thyroid inhibitor thyrotropin thyroxine triiodothyronine
项目摘要
Past and proposed work in this laboratory have included the
following major areas of clinical and basic research:
metabolism, protein binding and peripheral effects of the thyroid
hormones (TH); regulation of TSH secretion; effects of iodine on
thyroid function in man and rodents; and immunological aspects of
thyroid pathophysiology. A synthetic flavonoid, EMD 21388 (F),
which inhibits the serum protein binding (TBPA) of the TH and 5'-
deiodinase activity (5'-D) in vitro will be utilized to study, in
the rat, the in vivo effects of rapid displacement of the TH from
their major serum binding protein (TBPA) in peripheral tissues,
the possible thyromimetic effects of F in vivo and in vitro
(using GH producing tumor cell lines), and the possible in vivo
and in vitro inhibitory effects of F on 5'-D. Starvation and
other experimental conditions in the rat are associated with the
appearance of serum TBG (rTBG), and preliminary studies suggest
an enhanced response in females compared to males. This will be
further investigated to determine the possible etiology of this
finding. The prevalence of Familial Dysalbuminemic
Hyperthyroximenia (FDH), which appears to be relatively common,
especially in Puerto Rican families, will be determined by
studying families of newborns whose serum T4 concentration is at
least 2SD above the mean. The role of iodine intake on the
prevalence of thyroid dysfunction in the elderly and in the
pathogenesis of autoimmune thyroid diseases in man and in the
diabetes prone BB/Wor rat will continue to be addressed. New
immunosuppressant drugs (thalidomide and ciamexone) will be used
in an attempt to prevent the occurrence of spontaneous and iodine
induced lymphocytic thyroiditis (LT) in the BB/Wor rat. This
model will also be used to determine whether, as in humans,
transient LT is common during the post partum period. Finally,
preliminary retrospective studies suggest that chronic
levothyroxine therapy for hypothyroidism and for TSH suppression
in premenopausal women enhances bone loss. A prospective study
is now planned to confirm these observations. The overall aims
of this proposal is to provide further information on the binding
and peripheral metabolism and effects of the TH and to further
delineate the role of iodine and class II (Ia) antigen in the
etiology of autoimmune thyroid disease in man and rat.
该实验室过去和拟议的工作包括
主要临床和基础研究领域如下:
甲状腺的代谢、蛋白质结合和外周效应
激素(TH);调节 TSH 分泌;碘对的影响
人类和啮齿动物的甲状腺功能;和免疫学方面
甲状腺病理生理学。 一种合成类黄酮,EMD 21388 (F),
抑制 TH 和 5'- 的血清蛋白结合 (TBPA)
体外脱碘酶活性 (5'-D) 将用于研究
在大鼠中,TH 快速移位的体内效应
外周组织中的主要血清结合蛋白(TBPA),
F在体内和体外可能的拟甲状腺作用
(使用产生 GH 的肿瘤细胞系),以及可能的体内
以及F对5'-D的体外抑制作用。 饥饿和
大鼠的其他实验条件与
血清 TBG (rTBG) 的出现,初步研究表明
与男性相比,女性的反应增强。 这将是
进一步研究以确定这种情况的可能病因
发现。 家族性白蛋白血症的患病率
高甲状腺素血症(FDH)似乎相对常见,
特别是在波多黎各家庭中,将由
研究血清 T4 浓度为
至少比平均值高 2SD。 碘摄入量对身体的作用
老年人和老年人甲状腺功能障碍的患病率
人类自身免疫性甲状腺疾病的发病机制
易患糖尿病的 BB/Wor 大鼠将继续得到解决。 新的
将使用免疫抑制剂(沙利度胺和希美松)
以防止自燃和碘的发生
在 BB/Wor 大鼠中诱导淋巴细胞性甲状腺炎 (LT)。 这
模型还将用于确定是否像人类一样,
短暂性 LT 在产后期间很常见。 最后,
初步回顾性研究表明,慢性
左旋甲状腺素治疗甲状腺功能减退症和 TSH 抑制
绝经前妇女会增加骨质流失。 一项前瞻性研究
现在计划确认这些观察结果。 总体目标
该提案的目的是提供有关具有约束力的进一步信息
以及 TH 的外周代谢和影响,并进一步
描述碘和 II 类 (Ia) 抗原在
人和大鼠自身免疫性甲状腺疾病的病因学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lewis Braverman其他文献
Lewis Braverman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lewis Braverman', 18)}}的其他基金
123-I THYROID UPTAKE AT 24, 48, AND 72 HOURS FOLLOWING ADMINISTRATION OF RH-TSH
施用 RH-TSH 后 24、48 和 72 小时的 123-I 甲状腺摄取
- 批准号:
7379496 - 财政年份:2005
- 资助金额:
$ 29.68万 - 项目类别:
THYROID UPTAKE FOLLOWING ADMINISTRATION OF RH-TSH
施用 RH-TSH 后的甲状腺摄取
- 批准号:
7206295 - 财政年份:2004
- 资助金额:
$ 29.68万 - 项目类别:
REGULATION OF THYROID FUNCTION--T4 AND T3 KINETICS
甲状腺功能的调节——T4和T3动力学
- 批准号:
2015984 - 财政年份:1978
- 资助金额:
$ 29.68万 - 项目类别:
REGULATION OF THYROID FUNCTION T4 AND T3 KINETICS
甲状腺功能 T4 和 T3 动力学的调节
- 批准号:
3226219 - 财政年份:1978
- 资助金额:
$ 29.68万 - 项目类别:
REGULATION OF THYROID FUNCTION T4 AND T3 KINETICS
甲状腺功能 T4 和 T3 动力学的调节
- 批准号:
3226221 - 财政年份:1978
- 资助金额:
$ 29.68万 - 项目类别:
相似海外基金
Autoimmune disorder in hereditary angioedema
遗传性血管性水肿中的自身免疫性疾病
- 批准号:
26460654 - 财政年份:2014
- 资助金额:
$ 29.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of lymphocyte transmigration across the blood-brain barrier using an in vitro model that mimics blood flow and simulates inflammatory conditions as observed in the most frequent autoimmune disorder of the central nervous system, multiple sclero
使用体外模型模拟血流并模拟在中枢神经系统最常见的自身免疫性疾病多发性硬化症中观察到的炎症状况,从而研究淋巴细胞跨血脑屏障的迁移机制
- 批准号:
235301825 - 财政年份:2013
- 资助金额:
$ 29.68万 - 项目类别:
Research Fellowships
The challenge for the development of therapy for autoimmune disorder by the establishment of artificial thymic medullary organ
人工胸腺髓质器官的建立对自身免疫性疾病治疗发展的挑战
- 批准号:
23659241 - 财政年份:2011
- 资助金额:
$ 29.68万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research














{{item.name}}会员




